Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ANIFROLUMAB
- Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
- Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
- An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE)
- Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome
- Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab
- Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
- Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)
- Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
- Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE
- A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature (TarIFNiRA)
- A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations
- Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
- A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy Subjects
- Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
- Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
- Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Clinical trials list
click for details